New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses
PDF | Full Text | Supplementary Files | How to cite | Press Release
Metrics: PDF 1217 views | Full Text 2631 views | ?
Aysha AlSahlawi1,2,3,*, Rasha Aljelaify1,4,*, Amna Magrashi5, Mariam AlSaeed1,4, Amal Almutairi1,4, Fatimah Alqubaishi1,4, Abdulellah Alturkistani3, Abdullah AlObaid3, Mohamed Abouelhoda4,5, Latifa AlMubarak1,4, Nada AlTassan4,5 and Malak Abedalthagafi1,5,*
1 Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City and King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia
2 Montreal Neurological Institute, Montreal, Canada
3 Neurosurgery Department, King Fahad Medical City, Riyadh, Saudi Arabia
4 Saudi Human Genome Program, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia
5 Genetics Department, King Faisal Specialists Hospital and Research Center, Riyadh, Saudi Arabia
* These authors contributed equally to this work
|Malak Abedalthagafi,||email:||[email protected]|
Keywords: meningioma; FGFR3; NGS; genomics; CNS
Received: May 31, 2019 Accepted: August 12, 2019 Published: September 17, 2019
This study aimed to further investigate the association of mutational profiles with anatomical distribution, histological subtype, WHO grade, and recurrence in patients with meningioma.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.